Aortic pulse wave velocity in haemodialysis patients is associated with the prescription of active vitamin D analogues
- 29 January 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal Of Nephrology
- Vol. 27 (4) , 431-437
Abstract
Background Cardiovascular disease remains the most common cause of death for haemodialysis patients. In addition to traditional cardiovascular risk factors, haemodialysis patients have additional risk factors, including vascular calcification. Pulse wave velocity (PWV) is a measurement of arterial stiffness, and we wished to determine whether PWV is affected by different factors in haemodialysis patients compared to the general population. Methods Aortic PWV was measured in 303 adult patients attending for routine outpatient dialysis. Results 303 patients, 63.4 % male, mean age 68.5 ± 15.8 years, 47.5 % diabetic with a body mass index of 25.8 ± 5.3 kg/m2, were studied. Systolic blood pressure (SBP) was 148.7 ± 28.6 mmHg and diastolic 80.4 ± 15.3 mmHg. Aortic PWV was 9.73 ± 2.08 m/s, and was correlated with SBP (β 0.015, F 5.29, p = 0.023), log serum parathyroid hormone (PTH) (β 1.58, F 13.85, p < 0.001) and prescription of alfacalcidol (β −1.11, F 6.81, p = 0.010). 197 patients had corresponding ECHO cardiograms, and in this cohort PWV was associated with SBP (β 0.017, F 7.49, p = 0.006), log serum parathyroid hormone (β 0.85, F 5.99, p < 0.015) and prescription of alfacalcidol (β −0.8, F 4.18, p = 0.042), left ventricular mass index (LVMI) (β 0.01, F 11.4, p = 0.001), and log serum triglycerides (β 1.43, F 4.79, p = 0.03). Conclusions We found that PWV, a measurement of arterial stiffness, was associated with both traditional cardiovascular risk factors, including SBP and LVMI, but also non-traditional risk factors such as prescription of active vitamin D analogues, suggesting a potential link between vascular calcification and arterial stiffness in haemodialysis patients.Keywords
This publication has 32 references indexed in Scilit:
- Differences in prescribed Kt/V and delivered haemodialysis dose--why obesity makes a difference to survival for haemodialysis patients when using a 'one size fits all' Kt/V targetNephrology Dialysis Transplantation, 2013
- Risk factors associated with brachial–ankle pulse wave velocity among peritoneal dialysis patients in MacaoBMC Nephrology, 2012
- Weight gains and increased blood pressure in outpatient hemodialysis patients due to change in acid dialysate concentrate supplierThe International Journal of Artificial Organs, 2012
- Sudden Cardiac Death in Hemodialysis Patients: An In-Depth ReviewAmerican Journal of Kidney Diseases, 2011
- The Effect of Paricalcitol on Vascular Calcification and Cardiovascular Disease in Uremia: Beyond PTH ControlInternational Journal of Nephrology, 2011
- Invasive validation of a new oscillometric device (Arteriograph) for measuring augmentation index, central blood pressure and aortic pulse wave velocityJournal Of Hypertension, 2010
- N-terminal proBNP—Marker of Cardiac Dysfunction, Fluid Overload, or Malnutrition in Hemodialysis Patients?Clinical Journal of the American Society of Nephrology, 2010
- Embolic Complications From Central Venous Hemodialysis Catheters Used With Hypertonic Citrate Locking SolutionAmerican Journal of Kidney Diseases, 2010
- Validation of Arteriograph – A New Oscillometric Device to Measure Arterial Stiffness in Patients on Maintenance HemodialysisKidney and Blood Pressure Research, 2009
- Risk Factors for Incident Stroke among Patients with End-Stage Renal DiseaseJournal of the American Society of Nephrology, 2003